Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

Medications sold under brand names like Ozempic, Wegovy, and Saxenda have become famous for their weight-loss benefits, but ...

For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and MIDAS scores.

A recent study suggests that liraglutide, a drug similar to Ozempic, may reduce migraine frequency in obese individuals with ...

Subsequent hospitalization rates were lower among patients with type 2 diabetes who received liraglutide compared with glimepiride.

Oral DehydraTECH-liraglutide showed a pronounced reduction in adverse events (“AEs”) as compared to injected liraglutide (Saxenda (R)) Lexaria has now demonstrated, in distinct human clinical ...

Liraglutide, a medication commonly used to treat diabetes, has shown promising results in reducing chronic migraine in ...

A common diabetes drug may be the next big thing for migraine relief. In a clinical study, obese patients with chronic ...

“Our findings show liraglutide may be effective for treating stubborn, high-frequency migraines in patients with obesity, and ...

The Delhi High Court has instructed India's drug regulator to address concerns about the approval process for drugs like ...

The UK's medicines regulator has launched a study to investigate the impact of these drugs following reports of people dying ...

GLP-1 drug liraglutide could become a new treatment option for the estimated one in seven people worldwide who live with migraines ...